Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Experimental and Clinical Psychopharmacology is Scopus-indexed (Q2, CiteScore 4.1), WoS SCIE/SSCI. Published by American Psychological Association.
Checked against the index lists dated .
ISSN 1064-1297Verify ISSN ↗1936-2293Verify ISSN ↗
Publisher: American Psychological Association
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Psychiatry and Mental Health | 233 / 580 | 59th | Q2 |
| Pharmacology (medical) | 129 / 278 | 53rd | Q2 |
| Pharmacology | 178 / 328 | 45th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1993–present, best quartile Q2, CiteScore 4.1.
Experimental and Clinical Psychopharmacology is Q2 in Psychiatry and Mental Health (rank 233 of 580), Q2 in Pharmacology (medical) (rank 129 of 278) and Q3 in Pharmacology (rank 178 of 328), by CiteScore 2025.
Experimental and Clinical Psychopharmacology is indexed in the Science Citation Index Expanded and Social Sciences Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.1, which places it in quartile Q2 at the 59th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.796, quartile Q2, with an H-index of 105.
Experimental and Clinical Psychopharmacology is published by American Psychological Association. Its print ISSN is 1064-1297 and its online ISSN is 1936-2293.
Yes — indexed in the Science Citation Index Expanded and Social Sciences Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Experimental and Clinical Psychopharmacology has an h-index of 131 and a 2-year mean of 0.94 citations per paper (OpenAlex). Its Scopus CiteScore is 4.1, quartile Q2. On 2-year citations it ranks #382 of 570 Scopus journals in Psychiatry and Mental Health.
Experimental and Clinical Psychopharmacology published 88 papers in 2025; its busiest recent year was 2021 with 140. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from United States (87.8%), Australia (2%) and China (1.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.